// App-Quantinova.ai

350 : Prognostic value of simple blood biomarkers of systemic inflammation for metastatic renal cell carcinoma (mRCC) patients who undergo cytoreductive nephrectomy (CNx).

Researchers

Presenter

  • Jigi Moudgil-Joshi

Principal Investigators

  • Mark Stares

  • Alex Laird

  • Steve Leung

  • Jahangeer Malik

  • Aravindhan Sundaramurthy

  • Stefan N. Symeonides

Medical Centers

  • The University of Edinburgh, Edinburgh, United Kingdom

  • Western General Hospital, Edinburgh, United Kingdom

  • Edinburgh Cancer Research Center, University of Edinburgh, Edinburgh, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Nephrology

Disease

  • Metastatic Renal Cell Cancer

  • Systemic inflammation

  • Renal cell carcinoma

  • Solid malignancies

Biomarkers

  • C reactive protein

  • Human albumin

  • Kinase Insert Domain Receptor

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved